Obucort Swinghaler 200mcg/ dose (200 doses) Dry Powder for Inhalation in Capsule Philippines - English - FDA (Food And Drug Administration)

obucort swinghaler 200mcg/ dose (200 doses) dry powder for inhalation in capsule

otsuka (philippines) pharmaceutical, inc.; distributor: otsuka (philippines) pharmaceutical, inc. - budesonide - dry powder for inhalation in capsule - 200mcg/ dose (200 doses)

Salbucort Inhalation Vapour, Liquid Kenya - English - Pharmacy and Poisons Board

salbucort inhalation vapour, liquid

hetero labs ltd hetero corporate,h.no. 7-2-a2,industrial - salbutamol sulphate - inhalation vapour, liquid - 100mcg - adrenergics inhalants:

Salbucort Namibia - English - Namibia Medicines Regulatory Council

salbucort

hetro labs limited - salbutamol sulphate - inhaler - each metered dose contains salbutamo 100 mcg

NUCORT- hydrocortisone acetate lotion United States - English - NLM (National Library of Medicine)

nucort- hydrocortisone acetate lotion

gentex pharma - hydrocortisone acetate (unii: 3x7931po74) (hydrocortisone - unii:wi4x0x7bpj) - indications and usage: nucort lotion is a topical corticosteroid and is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. contraindications: topical corticosteroid products are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation. geriatric use: reported clinical experience has not identified differences in responses between the elderly and younger patients. in general, dose selection for an elderly patient should be cautious using the least amount compatible with an effective therapeutic regimen and reflecting the greater frequency of decreased hepatic, renal or cardiac function, and of concomitant disease or other drug therapy.

Pimafucort New Zealand - English - Medsafe (Medicines Safety Authority)

pimafucort

leo pharma limited - hydrocortisone 1%{relative} (1% overage added); natamycin 1%{relative};  ; neomycin sulfate 0.5%{relative} (10% overage added) - topical cream - active: hydrocortisone 1%{relative} (1% overage added) natamycin 1%{relative}   neomycin sulfate 0.5%{relative} (10% overage added) excipient: cetyl esters wax decyl oleate emulgade f macrogol stearates methyl hydroxybenzoate propyl hydroxybenzoate purified water sodium citrate sorbitan stearate

Pimafucort New Zealand - English - Medsafe (Medicines Safety Authority)

pimafucort

leo pharma limited - hydrocortisone 1%; natamycin 1%;  ; neomycin sulfate 0.35% - topical ointment - active: hydrocortisone 1% natamycin 1%   neomycin sulfate 0.35% excipient: liquid paraffin polyethylene

ANUCORT-HC- hydrocortisone acetate suppository United States - English - NLM (National Library of Medicine)

anucort-hc- hydrocortisone acetate suppository

cosette pharmaceuticals, inc. - hydrocortisone acetate (unii: 3x7931po74) (hydrocortisone - unii:wi4x0x7bpj) - hydrocortisone acetate 25 mg - hydrocortisone acetate suppositories are indicated for use in inflamed hemorrhoids, post-irradiation (factitial) proctitis; as an adjunct in the treatment of chronic ulcerative colitis; cryptitis; and other inflammatory conditions of anorectum and pruritus ani. hydrocortisone acetate suppositories are contraindicated in those patients having a history of hypersensitivity to hydrocortisone acetate or any of the components. drug abuse and dependence have not been reported in patients treated with hydrocortisone acetate suppositories.

ANUCORT-HC hydrocortisone acetate suppository United States - English - NLM (National Library of Medicine)

anucort-hc hydrocortisone acetate suppository

preferred pharmaceuticals, inc - hydrocortisone acetate (unii: 3x7931po74) (hydrocortisone - unii:wi4x0x7bpj) - hydrocortisone acetate 25 mg